Mounjaro/Zepbound Tracker App
Track Your Mounjaro/Zepbound Protocol
Mounjaro/Zepbound (Tirzepatide) is a gip+glp-1 dual agonist, FDA approved, used in SURMOUNT-1 with 20.9% weight loss at 72 weeks. Shotlee is the free app to track your complete Mounjaro/Zepbound protocol — doses, side effects, weight, and labs.
What Is Mounjaro/Zepbound?
Mounjaro/Zepbound (Tirzepatide) is a gip+glp-1 dual agonist, FDA approved, used in SURMOUNT-1 with 20.9% weight loss at 72 weeks. Shotlee is the free app to track your complete Mounjaro/Zepbound protocol — doses, side effects, weight, and labs.
Shotlee tracks every aspect of your Mounjaro/Zepbound protocol: injection dates, doses, sites, side effects, weight changes, and lab results. Whether you are starting or optimizing, clean data makes better decisions.
What to Track in Shotlee
Build a complete Mounjaro/Zepbound protocol record from day one.
How to Track Your Mounjaro/Zepbound Protocol
Mounjaro/Zepbound Key Facts
Protocol FAQs
Clinical trials show tirzepatide produces more weight loss (22% vs 15-17%) and better A1C reduction than semaglutide. However, individual results vary. Shotlee tracks both medications.
Sulfur burps (egg-smelling burps) are a unique side effect of tirzepatide not commonly seen with semaglutide. Shotlee helps you track this and identify triggers.
Yes! Many users get tirzepatide from telehealth providers. Shotlee supports custom dosing for compounded formulations.
Mounjaro is indicated for type 2 diabetes while Zepbound is for obesity. Your doctor can help decide. Shotlee tracks both identically.
Open the Shotlee app, navigate to the dose logging screen, select Tirzepatide as your medication, and enter the dose amount, injection site, and time. Shotlee stores all entries with timestamps and lets you view your complete dose history, adherence rate, and missed dose alerts. The app is free to download and use.
The most important side effects to track include gastrointestinal symptoms (nausea, vomiting, diarrhea, constipation), injection site reactions, appetite changes, energy levels, and any unusual symptoms. Log these daily in Shotlee so you can share accurate trend data with your healthcare provider at your next visit.
Most patients begin noticing appetite changes within the first one to two weeks. Measurable weight loss typically becomes apparent by weeks four to eight, depending on the dose titration schedule and individual metabolic response. Track your weekly weight in Shotlee to visualize your personal response curve over time.
Track Your Mounjaro/Zepbound Protocol in Shotlee
Free dose logs, side effect tracking, weight trends, and lab results — all in one app.
📚References & sources
Latest on Tirzepatide
Peptides and Health: The Truth Behind the Beauty and Weight Loss Claims
Peptides are the newest buzzword in health and beauty, promising everything from wrinkle reduction to profound weight loss. But does the science actually back up the claims, and are they safe?
7 min read
Navigating Medicare's New Path for GLP-1 Weight Loss Coverage
For years, Medicare coverage for GLP-1 medications like Ozempic and Wegovy was strictly limited to diabetes management. A significant shift is underway, however, as a new 'Bridge' program opens doors for weight loss coverage, albeit with specific requirements and nuances that patients must navigate.
6 min read
Ozempic, Wegovy, Mounjaro: How Do They Affect Mental Health?
New research sheds light on the neuropsychiatric effects of popular weight loss medications like semaglutide and tirzepatide. Discover how these treatments may influence anxiety, depression, and other mental health outcomes.
7 min read